Statin use and pneumonia risk in Parkinson's disease
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 91, 124-127
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Land, Infrastructure and Transport (07-2020-5030)
This publication has 12 references indexed in Scilit:
- Association between neurodegenerative diseases and pneumonia: a retrospective population-based studyCurrent Medical Research and Opinion, 2018
- Statin for Tuberculosis and Pneumonia in Patients with Asthma–Chronic Pulmonary Disease Overlap Syndrome: A Time-Dependent Population-Based Cohort StudyJournal of Clinical Medicine, 2018
- Higher serum cholesterol and decreased Parkinson's disease risk: A statin‐free cohort studyMovement Disorders, 2018
- Statins may facilitate Parkinson's disease: Insight gained from a large, national claims databaseMovement Disorders, 2017
- Statin use and risk of Parkinson’s disease: A meta-analysisBehavioural Brain Research, 2016
- Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson’s DiseaseAging and disease, 2016
- Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective studyMovement Disorders, 2015
- Statins in neurological disorders: An overview and updatePharmacological Research, 2014
- The Role of Statins in Prevention and Treatment of Community Acquired Pneumonia: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOPPLOS ONE, 2011